The pharmacokinetics, safety, tolerability and the effect on EPO levels after single oral doses of molidustat in healthy male volunteers.

Trial Profile

The pharmacokinetics, safety, tolerability and the effect on EPO levels after single oral doses of molidustat in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2018

At a glance

  • Drugs Molidustat (Primary)
  • Indications Anaemia
  • Focus First in man; Pharmacokinetics; Proof of concept
  • Most Recent Events

    • 13 Apr 2018 New trial record
    • 25 Mar 2018 Results published in the British Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top